US FDA News: FDA approves first treatment for thyroid eye disease

FDA approved Tepezza for the treatment of adults with thyroid eye disease. Today’s approval represents the first drug approved for the treatment of thyroid eye disease.
Read more: FDA approves first treatment for thyroid eye disease